darunavir
Selected indexed studies
- Darunavir: A comprehensive profile. (Profiles Drug Subst Excip Relat Methodol, 2021) [PMID:33461696]
- Darunavir. (Drugs Today (Barc), 2007) [PMID:17987220]
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection. (Drugs, 2018) [PMID:29915897]
_Worker-drafted node — pending editorial review._
Connections
darunavir is a side effect of
Sources
- Darunavir: A comprehensive profile. (2021) pubmed
- Darunavir. (2007) pubmed
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection. (2018) pubmed
- Darunavir for use in pregnant women with HIV. (2017) pubmed
- Darunavir for the treatment of HIV infection. (2018) pubmed
- Darunavir: A Review in Pediatric HIV-1 Infection. (2015) pubmed
- Darunavir: A Versatile Protease Inhibitor against Microbial Infections. (2025) pubmed
- Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance. (2022) pubmed
- Advancing darunavir delivery: nanoformulation strategies and innovations in HIV therapy. (2025) pubmed
- Darunavir Stands Up as Preferred HIV Protease Inhibitor. (2017) pubmed